PIPELINE
Overview
MM-093
About RA
About Psoriasis
About Uveitis
Pipeline: Overview

Merrimack is dedicated to the discovery and development of new and innovative treatments for autoimmune disease and cancer. For more information on a specific program, please click on the indications/product candidates below.

MM-093 Rheumatoid Arthritis
Psoriasis
Uveitis
Multiple Sclerosis
 
             
    > Back to Home
Site Design by Digizyme
 
About Pipeline Research & Development News & Events Careers Contact Merrimack Pharmaceuticals